Testing the Predictive Value of Peripheral Gene Expression for Nonremission Following Citalopram Treatment for Major Depression

Major depressive disorder (MDD) in general, and anxious-depression in particular, are characterized by poor rates of remission with first-line treatments, contributing to the chronic illness burden suffered by many patients. Prospective research is needed to identify the biomarkers predicting nonrem...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuropsychopharmacology
Auteurs principaux: Guilloux, Jean-Philippe, Bassi, Sabrina, Ding, Ying, Walsh, Chris, Turecki, Gustavo, Tseng, George, Cyranowski, Jill M, Sibille, Etienne
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2015
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4289958/
https://ncbi.nlm.nih.gov/pubmed/25176167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2014.226
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires